Utility of 3D Navigation to Reduce Ionizing Radiation in Common Flutter Ablation. Study of Personnel and Patient Dosimetry

NCT ID: NCT03946280

Last Updated: 2019-07-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-11-01

Study Completion Date

2020-11-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Common Flutter ablation technique use low X-ray based three-dimension (3D) navigation for catheter tracking, have become a popular implementation to treat patient's underlying arrhythmia. Compared with fluoroscopy, the gold standard X-ray based method, this recent technique provides the required anatomical information and reduce risk associated with ionizing radiation exposure. Besides Practical Guidelines "as low as reasonably achievable (ALARA) to minimize and normalize radiation exposure had been published so far. The risk of developing acute radiation associated injuries still remains high. In the present study we will compare two groups of patients undergoing into cavotricuspid isthmus (CTI) ablation using either the 3D navigation ("Ensite NavX system") (n = 25) or conventional fluoroscopy (n = 25). Further developing the 3D navigation technique will help to increase safety during the treatment, for both patients and the personnel and increase the success rate during the electrophysiological (EP) interventional procedures.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Auricular Flutter Radiation Exposure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized study, patients are allocated to 1 of the 2 groups
Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Fluoroscopy Group

Patient undergoing common flutter (AFL) ablation procedure using conventional X-ray based fluoroscopy for for catheter tracking

Group Type OTHER

conventional X-ray based Fluoroscopy

Intervention Type PROCEDURE

catheter tracking via conventional X-ray based Fluoroscopy

3D Group

Patient undergoing common flutter (AFL) ablation procedure using the low X-ray 3D navigation technique for for catheter tracking

Group Type EXPERIMENTAL

low X-ray 3D navigation technique

Intervention Type PROCEDURE

catheter tracking via low X-ray 3D navigation technique

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

conventional X-ray based Fluoroscopy

catheter tracking via conventional X-ray based Fluoroscopy

Intervention Type PROCEDURE

low X-ray 3D navigation technique

catheter tracking via low X-ray 3D navigation technique

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Sick adult patients with Atrial Flutter arrythmia
* patients able to consent.
* patients scheduled to receive cavotricuspid isthmus ablation treatment
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Christophe Scavée, PhD

Role: PRINCIPAL_INVESTIGATOR

Cliniques Universitaires St Luc

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cliniques Universitaires St Luc

Brussels, , Belgium

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Christophe Scavée, PhD, MD

Role: CONTACT

+3227642808

Yovan Sanchez Ruiz, PhD

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Yovan SANCHEZ RUIZ

Role: primary

Christophe SCAVEE

Role: backup

3227642808

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DOSIMETRY - FLUTTER

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Noninvasive Mapping Before Surgical Ablation
NCT06803615 ACTIVE_NOT_RECRUITING
Autonomic Innervation and MIBG Imaging
NCT02071680 COMPLETED PHASE3